We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » INITIAL SALES OF BOSTON SCIENTIFIC'S TAXUS STENT SOAR
INITIAL SALES OF BOSTON SCIENTIFIC'S TAXUS STENT SOAR
March 26, 2004
Early sales figures for Boston Scientific’s drug-coated Taxus stent indicate the device is well on its way to meeting the company’s goal of capturing 70 percent of the U.S. coronary stent market within 70 days of launch.